Understanding Variable Penetrance: Why Genetic Bone Loss Can Appear Late in Life

Understanding Variable Penetrance: Why Genetic Bone Loss Can Appear Late in Life

Genetic bone disorders don’t always follow a straight line from mutation to symptoms. In some families, members with the same gene variant may develop fractures or bone pain in childhood, while others remain symptom-free until middle age or later. This pattern reflects variable penetrance, and a prime example is Autosomal dominant hypophosphatemic rickets (ADHR). Below, we’ll explore how ADHR works, why bone loss can show up late, what to watch for, and how to take action.

What Is Autosomal Dominant Hypophosphatemic Rickets (ADHR)?

• ADHR is a rare inherited condition affecting phosphate metabolism.
• It’s caused by mutations in the FGF23 gene, which regulates phosphate levels in the blood.
• When FGF23 is overactive, it prompts the kidneys to waste phosphate, weakening bones over time.
• Symptoms often include bone pain, muscle weakness, fractures, and, in children, rickets (softening of growing bones).

Key points about ADHR:

• Inheritance: Autosomal dominant—each child of an affected parent has a 50% chance of inheriting the mutation.
• Penetrance: Not everyone with the mutation shows symptoms at the same age or intensity.
• Expressivity: The severity of phosphate loss and bone symptoms can vary widely, even within one family.

The Genetics Behind Late-Onset Bone Loss

Variable penetrance arises when the same genetic mutation does not always “turn on” disease processes in the same way or at the same time. In ADHR, several factors play a role:

1. FGF23 Cleavage and Stability

   • Mutations in FGF23 often reduce its ability to be cleaved (cut into inactive pieces).
   • Some people produce enough active FGF23 to cause phosphate loss early; others maintain near-normal levels until a trigger occurs.

2. Hormonal Changes

   • Puberty, pregnancy, menopause or hormone therapy can shift phosphate balance.
   • Estrogen and testosterone influence bone mineralization and kidney function, unmasking a borderline phosphate leak.

3. Dietary and Lifestyle Factors

   • High dietary phosphate, vitamin D intake, or certain medications (e.g., diuretics) may compensate for mild genetic phosphate loss.
   • A sudden diet change, illness or weight loss can tip the balance toward phosphate deficiency.

4. Age-Related Kidney Function Decline

   • As kidney filtration naturally slows with age, phosphate handling changes.
   • In someone with a borderline genetic phosphate leak, this decline can push them over the threshold into symptomatic ADHR.

Recognizing the Signs of Late-Onset ADHR

Because symptoms may creep in slowly, it’s easy to attribute early signs to aging. Watch for:

• Persistent bone or joint pain that doesn’t respond to over-the-counter remedies
• Muscle weakness or fatigue, especially in the thighs and shoulders
• Stress fractures in the legs, feet or hips without a clear injury
• Bone deformities (in adults, this may look like subtle bowing or vertebral compression)
• Dental problems such as weak tooth enamel or frequent cavities

If you notice these issues developing in your 30s, 40s or beyond—particularly if a parent or sibling has experienced similar problems—consider discussing genetic evaluation.

How ADHR Is Diagnosed

Diagnosis often requires a combination of clinical, laboratory and genetic tests:

1. Laboratory Tests

   • Serum phosphate: typically low
   • Alkaline phosphatase: elevated when bone turnover increases
   • Parathyroid hormone (PTH): usually normal or slightly elevated
   • FGF23 level: often high

2. Imaging Studies

   • X-rays may show thinning of cortical bone or stress fractures.
   • Dual-energy X-ray absorptiometry (DEXA) scans can track bone density loss over time.

3. Genetic Testing

   • Confirms mutations in the FGF23 gene.
   • Helps identify at-risk family members before symptoms appear.

Treatment and Management Strategies

Early recognition and treatment can prevent fractures and preserve mobility. Treatment plans usually involve:

• Oral Phosphate Supplements
  Restores serum phosphate levels but requires careful dosing to avoid side effects such as diarrhea and secondary hyperparathyroidism.

• Active Vitamin D (Calcitriol)
  Promotes intestinal phosphate absorption. Close monitoring of calcium levels is essential to prevent kidney stones.

• Burosumab (Anti-FGF23 Antibody)
  A newer medication designed to neutralize excess FGF23, improving phosphate balance and bone mineralization. Not yet approved for everyone with ADHR, but clinical trials show promise.

• Lifestyle and Diet Adjustments

  • A balanced diet with adequate protein, calcium and vitamin D.
  • Weight-bearing exercise tailored to avoid stress fractures.
  • Avoidance of medications that worsen phosphate loss (e.g., certain diuretics, anticonvulsants).

Monitoring and Follow-Up

Because variable penetrance means symptoms can wax and wane, ongoing care is crucial:

• Repeat labs (serum phosphate, calcium, PTH) every 3–6 months.
• Annual bone density scans.
• Regular dental checkups if enamel defects are present.
• Prompt evaluation of new or worsening bone pain.

Why Late-Onset ADHR Matters

• Unexpected Fractures: Adults may surprise themselves with fractures from routine activities, setting back mobility.
• Misdiagnosis Risk: Late bone pain can be misattributed to arthritis, vitamin D deficiency, or age-related osteoporosis.
• Family Planning: Identifying ADHR early helps potential parents understand inheritance risks and consider prenatal or early genetic counseling.
• Quality of Life: Timely treatment reduces pain, improves strength and prevents deformities.

What You Can Do Now

• Review your family history for early fractures, rickets, or unexplained bone pain.

• Track any persistent muscle weakness or bone pain that interferes with daily life.

• If you suspect ADHR or another bone-weakening condition, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

  free, online symptom check, using the doctor approved Ubie Symptom Checker

• Ask your primary care provider about laboratory tests for phosphate, FGF23 and vitamin D levels.

• Seek referral to an endocrinologist or geneticist if initial tests are abnormal.

When to Speak to a Doctor

While ADHR can sometimes be managed with supplements and medication, untreated phosphate loss may lead to serious complications:

• Multiple fractures or non-healing stress fractures
• Severe bone deformities affecting mobility
• Electrolyte imbalances (calcium, phosphate) that impact heart or kidney function

If you experience any life-threatening symptoms—such as sudden bone collapse, severe electrolyte disturbance, or marked muscle weakness—please speak to a doctor immediately.

---

Understanding variable penetrance and conditions like Autosomal dominant hypophosphatemic rickets ADHR empowers you to spot late-life bone loss, seek timely testing, and access treatments that protect your bones. Early action, informed by family history and simple lab tests, can make all the difference in preserving strength and preventing fractures. If in doubt, always reach out to your healthcare provider for personalized advice.